Skip to main content
Signal8
Bodenhoff Mads profile photo

Mads Bodenhoff

CIK: 0002014697

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ascendis Pharma A/S logo
ASND

Ascendis Pharma A/S

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Ascendis Pharma A/S logo
    ASND

    Ascendis Pharma A/S

    Sep 8, 2026
    Exercise(M)
    Direct
    3K shares at avg. $110.00$330K
  • Ascendis Pharma A/S logo
    ASND

    Ascendis Pharma A/S

    Sep 8, 2026
    Sale(S)
    Direct
    3K shares at avg. $270.19$811K

1-2 of 2

About Bodenhoff Mads

Bodenhoff Mads (SEC CIK 0002014697) files insider reports with the SEC as SVP & PAO of Ascendis Pharma A/S (ASND).

Signal8 holds 2 ownership filings by Bodenhoff Mads (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Sep 9, 2026. Those filings report 2 transactions, the latest on Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bodenhoff Mads's filings is in HELLERUP.

Recent filings by Bodenhoff Mads

  • Sep 8, 2026: Option exercise of ASND shares (Form 4, code M).
  • Sep 8, 2026: Open-market sale of ASND shares (Form 4, code S).

Other insiders filing for Ascendis Pharma A/S (ASND)

How to read Form 4 transaction codes